1/ Myocarditis rates reported in VAERS were significantly higher in youths between the ages of 13 to 23 (p<0.0001) with ∼80% occurring in males. They found 19 times the expected number of myocarditis cases in the vaccination volunteers over background.
2/ In addition, a 5-fold increase in myocarditis rate was observed subsequent to dose 2 as opposed to dose 1 in 15-year-old males.
3/ Of the total myocarditis reports, 6 individuals died (1.1%) and of these, 2 were under 20 years of age - 1 was 13.
1/ “Fully vaccinated were more likely than unvaccinated persons to be infected by variants carrying mutations associated with decreased antibody neutralization.”, and “In unvaccinated cases, most viruses consisted of non-resistant variants”
2/ In addition, the increase in the frequency of more antibody-resistant strains in the population correlates with the increase in the frequency of vaccination in the population
3/ “and the percentage of sequenced cases that were vaccine breakthroughs increased from 0% to 31.8% from February to June”
1/ “Of the 42 cases diagnosed in this outbreak, 38 were fully vaccinated…
The calculated attack rate among all exposed patients and staff was 10.6% for staff and 23.7% for patients, in a population with 96.2% vaccination rate”.
2/ On the day of diagnosis, only 24 individuals were symptomatic, but in the following days, 36 had become symptomatic. Among the patients, eight became severely ill, six critically ill and five of the critically ill died.
3/ “Moreover, several transmissions probably occurred between two individuals both wearing surgical masks, and in one instance using full PPE, including N-95 mask, face shield, gown and gloves.”
Comparison of neutralization titers over 6 months in young adults (Control) and Nursing Home Residents. Two Subgroups: 1) Prior Infection then Vaccinated. 2) Infection Naive then Vaccinated. Those with prior infection demonstrate greater capacity for sustained neutralization.
Even though the median drops about 18 fold over 6 months in both subgroups, those with prior infection maintain a ~3-4 fold higher neutralization titer over the course of 6 months post vax, with a larger percentage of spread above the median than the infection naive.
In addition, approximately 70% of the infection naive group in nursing home residents demonstrated neutralization titers that were below the lower limit of detection (LLD) after 6 months post vax.
I’m censored the most when I discuss the risk of DNA modification. <1month after I publicly made this prediction, MIT/Harvard came out with their 1st paper proving this possibility with viral RNA snippets. They were attacked. Why is this impossible? It’s clearly not.
1/This shows Spike protein and S1 in the plasma of vaccinated people for up to 28 days after injection. Levels peak at ~150 pg/mL, which is in the concentration range of Spike measured in COVID patients. Now, who said Spike remains at the injection site or in the cell membrane?
3/ The Pfizer Vaxx shows a similar profile, with circulating plasma Spike concentration returning to baseline in less than month after first and second dose. They claim 14 ug/mL peak, but describe how this high level doesn’t correlate with Ogata et al. mdpi-res.com/d_attachment/s…